These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8574968)

  • 1. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients.
    Riddell SR; Elliott M; Lewinsohn DA; Gilbert MJ; Wilson L; Manley SA; Lupton SD; Overell RW; Reynolds TC; Corey L; Greenberg PD
    Nat Med; 1996 Feb; 2(2):216-23. PubMed ID: 8574968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene combination raises broad human immunodeficiency virus-specific cytotoxicity.
    Calarota SA; Kjerrström A; Islam KB; Wahren B
    Hum Gene Ther; 2001 Sep; 12(13):1623-37. PubMed ID: 11535166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of human immunodeficiency virus (HIV)-specific CD8 T-cell responses by Listeria monocytogenes and a hyperattenuated Listeria strain engineered to express HIV antigens.
    Friedman RS; Frankel FR; Xu Z; Lieberman J
    J Virol; 2000 Nov; 74(21):9987-93. PubMed ID: 11024127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Putative immunodominant human immunodeficiency virus-specific CD8(+) T-cell responses cannot be predicted by major histocompatibility complex class I haplotype.
    Betts MR; Casazza JP; Patterson BA; Waldrop S; Trigona W; Fu TM; Kern F; Picker LJ; Koup RA
    J Virol; 2000 Oct; 74(19):9144-51. PubMed ID: 10982361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen burden is major determinant of human immunodeficiency virus-specific CD8+ T cell maturation state: potential implications for therapeutic immunization.
    Tussey LG; Nair US; Bachinsky M; Edwards BH; Bakari J; Grimm K; Joyce J; Vessey R; Steigbigel R; Robertson MN; Shiver JW; Goepfert PA
    J Infect Dis; 2003 Feb; 187(3):364-74. PubMed ID: 12552420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Principles for adoptive T cell therapy of human viral diseases.
    Riddell SR; Greenberg PD
    Annu Rev Immunol; 1995; 13():545-86. PubMed ID: 7612234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal study of HIV-specific cytotoxic lymphocytes in HIV type 1-infected patients: relative balance between host immune response and the spread of HIV type 1 infection.
    Bariou C; Genetet N; Ruffault A; Michelet C; Cartier F; Genetet B
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1301-12. PubMed ID: 9339847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.
    Wilson SE; Pedersen SL; Kunich JC; Wilkins VL; Mann DL; Mazzara GP; Tartaglia J; Celum CL; Sheppard HW
    AIDS Res Hum Retroviruses; 1998 Jul; 14(11):925-37. PubMed ID: 9686639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary proliferative and cytotoxic T-cell responses to HIV induced in vitro by human dendritic cells.
    Macatonia SE; Patterson S; Knight SC
    Immunology; 1991 Nov; 74(3):399-406. PubMed ID: 1769689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of adoptive immunotherapy with autologous CD8+ T lymphocytes on immunologic parameters: lymphocyte subsets and cytotoxic activity.
    Torpey D; Huang XL; Armstrong J; Ho M; Whiteside T; McMahon D; Pazin G; Heberman R; Gupta P; Tripoli C
    Clin Immunol Immunopathol; 1993 Sep; 68(3):263-72. PubMed ID: 8370181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups.
    Mollet L; Li TS; Samri A; Tournay C; Tubiana R; Calvez V; Debré P; Katlama C; Autran B
    J Immunol; 2000 Aug; 165(3):1692-704. PubMed ID: 10903781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocytosis of an HIV-derived lipopeptide into human dendritic cells followed by class I-restricted CD8(+) T lymphocyte activation.
    Andrieu M; Loing E; Desoutter JF; Connan F; Choppin J; Gras-Masse H; Hanau D; Dautry-Varsat A; Guillet JG; Hosmalin A
    Eur J Immunol; 2000 Nov; 30(11):3256-65. PubMed ID: 11093141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
    Carmichael A; Jin X; Sissons P; Borysiewicz L
    J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution of anti-HIV effector functions of primary human CD8 T lymphocytes by transfer of HIV-specific alphabeta TCR genes.
    Ueno T; Fujiwara M; Tomiyama H; Onodera M; Takiguchi M
    Eur J Immunol; 2004 Dec; 34(12):3379-88. PubMed ID: 15517606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
    Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC
    J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
    Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
    J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II.
    SenGupta D; Norris PJ; Suscovich TJ; Hassan-Zahraee M; Moffett HF; Trocha A; Draenert R; Goulder PJ; Binder RJ; Levey DL; Walker BD; Srivastava PK; Brander C
    J Immunol; 2004 Aug; 173(3):1987-93. PubMed ID: 15265933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes.
    Andrieu M; Chassin D; Desoutter JF; Bouchaert I; Baillet M; Hanau D; Guillet JG; Hosmalin A
    AIDS Res Hum Retroviruses; 2001 Sep; 17(14):1365-70. PubMed ID: 11602047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation between phenotype activation markers of CD8 lymphocytes and cytotoxic T lymphocyte (CTL) function in HIV-1 infection: evidence for rescue with rIL-2.
    Chia WK; Nisbet-Brown E; Li X; Salit I; Joshi S; Read SE
    Viral Immunol; 1994; 7(2):81-95. PubMed ID: 7848511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.